Company performance
Current Price
as of Dec 10, 2024$90.98
P/E Ratio
15.12
Market Cap
$6.33B
Description
Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the U.S. and International geographical segments. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America. The company was founded in 1956 and is headquartered in Bedford, MA.
Metrics
Overview
- HQBedford, MA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerLNTH
- Price$90.98-1.73%
Trading Information
- Market cap$6.33B
- Float97.51%
- Average Daily Volume (1m)1,192,549
- Average Daily Volume (3m)978,135
- EPS$6.20
Company
- Revenue$1.50B
- Rev growth (1yr)18.37%
- Net income$131.09M
- Gross margin63.93%
- EBITDA margin39.82%
- EBITDA$150.82M
- EV$7.77B
- EV/Revenue5.19
- P/E15.12
- P/S4.44
- P/B5.46